How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study - Concepedia

Concepedia

Publication | Closed Access

How ADAM-9 and ADAM-11 Differentially From Estrogen Receptor Predict Response to Tamoxifen Treatment in Patients with Recurrent Breast Cancer: a Retrospective Study

86

Citations

33

References

2005

Year

Anieta M. Sieuwerts, Marion E. Meijer‐van Gelder, Mieke Timmermans, Anita M.A.C. Trapman, Roberto Rodríguez García, Miranda Arnold, Anneke J.W. Goedheer, Henk Portengen, Jan G.M. Klijn, John A. Foekens

Clinical Cancer Research

Abstract

Our results show that especially for primary tumors containing stromal elements, the assessment of mRNA expression levels of ADAM-9 and ADAM-11 could be useful to identify patients with recurrent breast cancer who are likely to benefit or fail from tamoxifen therapy.

References

	Year	Citations

Page 1